Paradis H, Gaudreau P, Massie B, Lamarche N, Guilbault C, Gravel S, Langelier Y
Institut du Cancer de Montréal, Québec, Canada.
J Biol Chem. 1991 May 25;266(15):9647-51.
Herpes simplex virus (HSV) ribonucleotide reductase is formed by the association of two distinct dimeric subunits, R1 and R2. Attempts to purify either the HSV holoenzyme or its R1 subunit in their active form have been unsuccessful until now. The C terminus of the R2 protein being involved in the association with R1, the synthetic nonapeptide corresponding to this terminus, impedes the formation of the holoenzyme by competing with R2 for a critical site on R1. Based upon these observations, we developed an affinity chromatographic procedure to purify the R1 protein from HSV-1-infected baby hamster kidney cells. Specific binding of R1 to an affinity column made by linking the peptide HSV R2-(326-337) to Affi-Gel 10, followed by specific elution with an excess of an analogous peptide exhibiting a higher affinity for R1 yielded, in a single step, highly purified R1 protein. The purified R1 preparations contained approximately 95% of intact R1, the remaining 5% consisting of two R1 copurifying proteolytic breakdown products. The purified R1 protein exhibited a high reductase specific activity when mixed with an excess of the R2 subunit. Moreover, in vitro kinase assays revealed that the purified R1 protein of HSV-1 possesses an autophosphorylating activity also able to phosphorylate alpha-casein and histone II-S. The intrinsic protein kinase activity of HSV R1 is associated with its unique N-terminal domain which is absent from all other reductase subunits 1 and contains consensus motifs found in Ser/Thr protein kinases. A preliminary characterization of the kinase activity of the R1 protein of HSV-1 ribonucleotide reductase is presented.
单纯疱疹病毒(HSV)核糖核苷酸还原酶由两个不同的二聚体亚基R1和R2结合形成。此前,纯化处于活性形式的HSV全酶或其R1亚基的尝试均未成功。由于R2蛋白的C末端参与与R1的结合,对应于该末端的合成九肽通过与R2竞争R1上的关键位点来阻碍全酶的形成。基于这些观察结果,我们开发了一种亲和色谱法,用于从感染HSV-1的幼仓鼠肾细胞中纯化R1蛋白。R1与通过将肽HSV R2-(326 - 337)连接到Affi-Gel 10制成的亲和柱特异性结合,然后用过量的对R1具有更高亲和力的类似肽进行特异性洗脱,一步得到了高度纯化的R1蛋白。纯化的R1制剂中约95%为完整的R1,其余5%由两种与R1共纯化的蛋白水解降解产物组成。纯化的R1蛋白与过量的R2亚基混合时表现出高还原酶比活性。此外,体外激酶测定表明,HSV-1的纯化R1蛋白具有自磷酸化活性,也能够磷酸化α-酪蛋白和组蛋白II-S。HSV R1的内在蛋白激酶活性与其独特的N末端结构域相关,该结构域在所有其他还原酶亚基1中均不存在,并且包含丝氨酸/苏氨酸蛋白激酶中发现的共有基序。本文对HSV-1核糖核苷酸还原酶R1蛋白的激酶活性进行了初步表征。